The Saudi Food & Drug Authority (SFDA) released guidelines for Economic Evaluation Studies to assess...
Read moreGermany's new Medicines Research Act allows confidential rebates for pharma companies, but recent am...
Read moreWe explore CAR T-cell therapy challenges, regulatory approvals, market growth, pricing models, and a...
Read moreThe study explores the complexities of pricing and reimbursement for multi-indication products in th...
Read moreThe World Evidence, Pricing, and Access (EPA) Congress stands as Europe’s premier event in mar...
Read moreThis expert article focusses on the new proportionate approach, and the international recognition pr...
Read moreWe've updated our 2019 analysis which compares the annual and lifetime treatment costs of the 10 mos...
Read moreOur study compares and contrasts the evaluation and reimbursement pathways for digital therapeutics ...
Read moreThis article explores the significant disparities between the US and Europe regarding orphan drugs a...
Read moreThe Centers for Medicare and Medicaid Services has unveiled a list of 10 drugs to undergo Medicare p...
Read more